Provide recombinant placental alkaline phosphatase (PLAP) for millions of
people to prevent their early death by safely reducing or even reversing muscle
wasting caused by cancer, cancer therapies, obesity, type 2 diabetes, and/or old
A Key Point
In contrast to the prevailing view, our science strongly supports the view that to
avoid cancer cachexia, suitable treatment of patients must preferably start right
after tumor detection. PLAP is being developed, in part, toward that goal.